Compare BVS & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BVS | VINP |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 716.8M | 638.8M |
| IPO Year | 2016 | 2020 |
| Metric | BVS | VINP |
|---|---|---|
| Price | $10.48 | $9.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $14.00 | $14.00 |
| AVG Volume (30 Days) | ★ 599.9K | 61.4K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.72% |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | $18.07 |
| Revenue Next Year | $7.06 | $12.74 |
| P/E Ratio | $262.00 | ★ $24.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $9.20 |
| 52 Week High | $11.25 | $13.61 |
| Indicator | BVS | VINP |
|---|---|---|
| Relative Strength Index (RSI) | 66.54 | 49.67 |
| Support Level | $8.42 | $9.66 |
| Resistance Level | $11.00 | $10.24 |
| Average True Range (ATR) | 0.40 | 0.39 |
| MACD | 0.18 | 0.04 |
| Stochastic Oscillator | 99.59 | 35.04 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.